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ABSTRACT Males ofDrosophila melanogaster lacking the
Y chromosome-linked crystal locus show multiple meiotic
alterations, including chromosome disorganization and
prominent crystal formation in primary spermatocytes. These
alterations are due to the derepression of the X chromosome-
linked Stellate sequences. To understand how the derepres-
sion of the Stellate elements gives rise to these abnormalities,
we have expressed the protein encoded by the Stellate se-
quences in bacteria and produced an antibody against the
fusion protein. Immunostaining of crystal- testes has clearly
shown that the Stellate protein is a major component of the
crystals. Moreover, in vitro experiments have shown that this
protein can interact with the catalytic a subunit of casein
kinase 2 enzyme, altering its activity.
The Y chromosome is known to be essential for male fertility
in Drosophila melanogaster (1). Previous work demonstrated
that many aspects of the XO phenotype reflect an unusual
negative regulatory interaction that normally occurs between
the X chromosome-linked Stellate (Ste) locus and the Y
chromosome-linked crystal (cry) or Suppressor of Stellate
[Su(Ste)] locus (2-6). That is, the Ste and cry loci are normally
silent. Deficiencies of cry lead to the derepression of the Ste
elements in the male germ line (3, 4, 7) and lead to the mutant
phenotype. Males lacking the Y-linked cry locus exhibit needle
or star-shaped crystalline aggregates in the nuclei and the
cytoplasm of primary spermatocytes (2, 8) and several other
meiotic defects such as an undercondensation of meiotic
chromosomes (9) and an altered distribution of mitochondria,
leading, in many cases, to complete sterility. Both the forma-
tion and shape of crystals and the strength of the other meiotic
abnormalities depend on the allelic state of the X-linked Ste
locus (2, 6). Males carrying a cry- Y chromosome and a Ste
allele show star-shaped crystals and are sterile. cry- males
carrying Ste+ alleles show needle-shaped crystals and are
somewhat fertile, but they evince genetic abnormalities such as
nondisjunction and meiotic drive (2, 6). The Ste and cry loci are
composed of homologous repetitive sequences (3, 4). The cry
locus contains about 80 copies of an 800-bp Cfo I fragment (3),
and Ste contains three classes of repeats giving 950-, 1100-, and
1150-bp Cfo I fragments (3, 6). The repeats are present in more
than 200 copies in Ste alleles, whereas they are an order of
magnitude less abundant in Ste+ (3, 6). By high-resolution
fluorescent in situ hybridization to larval neuroblast chromo-
somes, the cry locus has been localized to the hit region (6) of
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the mitotic prometaphase map of the Y chromosome (10). Two
clusters of the Ste sequences have also been localized, one to
the 12E1-2 euchromatic region of the X-polytene chromosome
map, and the other to the h27 region of the mitotic promet-
aphase heterochromatin map of the X chromosome (6).
The Ste sequences contain two introns and are efficiently
and correctly transcribed only in testes of cry- males, produc-
ing an abundant 750-bp poly(A)+ transcript that is absent in
wild-type males (4). Sequence analysis has revealed that the
Ste protein shares extensive homology with the 1B subunit of
casein kinase 2 (CK2) (4, 11, 12), an enzyme that is able to
aggregate in filamentous structures (13) and, among its mul-
tiple functions (14), is involved in topoisomerase II activity
(15), which is essential for chromosome condensation and
segregation (16-18).
To further examine the relationship among the Ste protein,
CK2, and the cry- phenotype, we isolated antibodies against a
Ste fusion protein. Using this antibody, we show here that the
Ste protein is absent in XY males but is a major component of
the crystalline aggregates in cry- males. We have used the
bacterially expressed Ste protein in in vitro assays to show that
it can interact with the a subunit of CK2 to form a complex
exhibiting some properties of an active a2f32 holoenzyme.
MATERIALS AND METHODS
Construction of the MS2-Stellate Fusion Protein and Pro-
duction of a Polyclonal Ste Antibody. Restriction analyses,
genetic engineering procedures, and Western blots were per-
formed as described (19). Sequences of the clones of interest
were performed using a Sequenase version 2.0 kit (United
States Biochemical).
A 17-mer (5'-TGCACGTAGTCGGTGGG-3') derived
from the Stellate sequence was used as primer. Computer
analysis was performed using GLORiA and ACNUC packages
developed by the Bioinformatic Group from CNR Research
Area ofBARI (Italy) and resident at the Italian EMBnet node
in Tecnopolis (Valenzano-Bari).
To construct the Ste expression vector, we used a clone,
named Gl (kindly provided by K. J. Livak, Central Research
and Development, E. I. DuPont de Nemours Experimental
Station, Wilmington, DE), consisting of an 843-bp EcoRI
fragment inserted in the pIBI30 vector. To subclone only the
protein-producing sequence, a 665-bp Sac I-EcoRI fragment,
obtained by digestion of Gl DNA, was inserted in Sac
I-EcoRI-digested pUC19 (20). The resulting subclone was
designated pUSTE6. TG1 CaCl2 competent cells were trans-
Abbreviation: CK2, casein kinase 2.
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formed with standard techniques. To express the Stellate
protein, the pEX34 bacterial expression system was chosen.
This system allows cloning in all three frames and produces a
fusion protein linked to the NH2-terminal region (about 10,000
Da) of MS2 polymerase (21). DHK12 electrocompetent cells
were transformed by electroporation (19). pUSTE6 was di-
gested with BamHI-EcoRI, and a 660-bp fragment was ob-
tained, which codes for 171 amino acids of Stellate protein.
This fragment was inserted in the pEX34b expression vector
digested with BamHI-Bgl II (EcoRI site of the fragment and
Bgl II site of the plasmid were previously filled in with the
Klenow fragment of DNA polymerase to allow cloning in the
right orientation). After cell transformation by electropora-
tion, screening for positive clones was performed using SDS/
12% PAGE by searching for the expression of MS2-Stellate
fusion protein after temperature induction. The screening for
production of fusion protein after induction was performed as
described (21). After induction, one of the transformed clones
that produced a band of the expected size for a chimeric
protein (-29,000 Da) was identified. This clone was desig-
nated pEXS6. The correct reading frame of the fusion protein
was checked by sequence analysis using as primer an oligonu-
cleotide hybridizing to the 5' end of the cloned Stellate
fragment. The purification of the fusion protein was per-
formed as described (21). The band corresponding to the
fusion protein was cut directly from the gel and used to
immunize mice. The antiserum (TS1) raised against MS2-
Stellate fusion protein was analyzed by Western blot on pEXS6
extracts.
Immunofluorescence. For indirect immunofluorescence,
testis preparations were fixed as described (22). After washing
three times in PBS (5 min each), the slides were incubated for
1 hr with 20 ,ul ofTS1 antiserum diluted 1:15 in PBS. They were
then washed two times in PBS, incubated for 1 hr with the
secondary antibody [fluorescein-labeled sheep anti-mouse im-
munoglobulin, F(ab')2 fragment; Boehringer Mannheim] di-
luted 1:20 in PBS, washed thoroughly with PBS, and mounted
in PBS. Sequential staining with Hoechst 33258 was performed
according to Palumbo et at (6). Fluorescent images with the
different stainings were recorded separately by a cooled
charge-coupled device camera (Photometrics) as grey-scale
digital images and then pseudocolored and merged by the
ADOBE PHOTOSHOP program.
In Vitro Assay for Binding of the Ste Protein to the CK2 a
Subunit. Recombinant a and 3 subunits of human protein
kinase CK2 were prepared as described (23). Rat liver CK2 was
purified to near homogeneity essentially as reported by Meggio
et at (24) with a subsequent FPLC Mono Q (Pharmacia)
chromatographic step. CK2 phosphorylation activity toward
synthetic peptide substrates was monitored essentially as de-
scribed (25), except for the presence in all experiments of 0.2
M urea in the phosphorylation assay. The phosphorylation of
calmodulin and the evaluation of the phosphate incorporated
were accomplished as described by Meggio et at (26). For the
thermal inactivation assay, isolated CK2 a subunit, either
alone or after addition of the Ste fusion protein, was prein-
cubated at 45'C for 0-10 min in 50 mM Tris*HCl (pH 7.5)/0.2
M urea. The samples were immediately ice cooled, and the
residual activity was determined as described above. Control
experiments were performed by replacing the Ste fusion
protein with either CK2 f3 subunit or bovine serum albumin.
For the sucrose density gradient analysis, sucrose density
ultracentrifugation of the Ste fusion protein either alone or
added in 17-fold molar excess to the a subunit was run in the
presence of 0.2 M urea for 15 hr at 37,000 rpm in a Beckman
SW39 rotor. Twenty fractions were collected and analyzed onSDS/15% PAGE after precipitation with 20% (wt/vol) tri-
chloroacetic acid in the presence of 2 ,ug of bovine serum
albumin. The immunodetection of the Ste protein on theblotted gels was evaluated with specific Ste antibody.
RESULTS AND DISCUSSION
Immunolocalization of the Ste Protein in Testes. The coding
sequence of a Stellate cDNA previously obtained by Livak (4)
was subcloned in pEX34 bacterial expression vector, and the
fusion protein was used to immunize mice. We obtained a
polyclonal antibody, denoted TS1, that reacts with a single
band of the expected size of 29,000 Da present exclusively in
the induced pEXS6 extracts (Fig. la). This antibody identifies
the Ste protein as a single band on Western blots of protein
extracts of only cry- males (Fig. lb). The protein recognized
by TS1 migrates as a 20,000-Da protein on SDS/PAGE. It is
abundant and visible after Coomassie blue staining of testis
extracts of cry- males, but it is not detected in extracts of
normal males (data not shown).
To examine the cellular localization of the Ste protein in the
male germ line, the TS1 antibody was used to immunostain
primary spermatocytes in cry- males. We prepared testis
squashes from males with two different sex chromosome
constitutions: X, Salve-i Ste+/cry- Y and X, 301.2 Ste/cry- Y.
The cry- Y corresponds to the Df(Y) cryl that lacks the cry
locus (6); the X, Salve-i Ste' chromosome carries 52 copies of
the Ste sequences, while the X, 301.2 Ste chromosome carries
300 copies (6). Previous studies (6) have shown that these two
X chromosomes result in crystals with distinct morphologies as
visualized with phase-contrast microscopy. As shown in Fig. 2
a-d, the antibody decorates the needle-shaped cytoplasmic
crystalline aggregates that are easily visible under phase-
contrast microscopy in the spermatocytes of Salve-I Ste+/cry-
males. In addition, we detect a number of small, often star-
shaped nuclear crystals located within spermatocyte nuclei
(Fig. 2d). Immunostaining also reveals that both intranuclear
and cytoplasmic crystals first appear in very young spermato-
cytes; at this stage, a fluorescent spot is visible within each
nucleus, which eventually develops into a star-shaped aggre-
gate in mature spermatocytes (Fig. 2 a and b). In addition, a
few needle-shaped crystals are visible (Fig. 2b); they are
irregularly distributed within the cytoplasm and progressively
increase in size in more mature stages. Interestingly, in the
cytoplasm of fully grown spermatocytes, a myriad of tiny
needle-shaped crystals can be clearly observed (Fig. 2d). These
are probably responsible for the homogeneous cytoplasmic
staining observed in earlier stages. Conspicuous star-shaped
crystals can be observed in both the nuclei and the cytoplasm
of primary spermatocytes of 301.2 Ste/cry- males (Fig. 2 e and
f). As above, the intranuclear aggregates start to develop from
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FIG. 1. (a) Western blot analysis of bacterial extracts incubated
with the TS1 antiserum. Lane 1, purified induced extract of pEXS6;
lane 2, induced pEXS6 extract; lane 3, extract of pEXS6 with no
induction. It is clear that the TS1 antiserum is specific for the
MS2-Stellate fusion protein (29,000 Da) and does not react with the
noninduced pEXS6 extracts. (b) Western blot of Drosophila testis
extracts incubated with the TS1 antiserum. Lane 1, extract from 301.2
Ste/cry- males; lane 2, extract from 301.2 Ste/cry+ males. A band of
20,000 Da hybridizes with the antiserum only in the lane of the extracts
of 301.2Ste/cry- males, indicating that it corresponds to the Ste
protein.
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FIG. 2. Immunofluorescence staining of testes from males of different genetic constitutions. Phase contrast (a and c) and immunofluorescence(b and d) of Salvel Ste+/cry- are shown. (a and b) Young spermatocyte cysts showing the development of the star-shaped intranuclear crystals
and the conspicuous needle-shaped cytoplasmic crystals. (c and d) Mature spermatocytes exhibiting fully developed intranuclear star-shaped
crystals, huge needle-shaped aggregates (arrowheads), and a myriad of tiny crystals scattered in the cytoplasm. Phase contrast (e) andimmunofluorescence (f) of 301.2 Ste/cry- are shown. Mature spermatocytes showing fully grown star-shaped aggregates. (g and h) Sperm bundles
of Salvel Ste+/cry-. Note that in g some bundles show regular heads (arrowheads), whereas in h all the bundles are full of crystals (long arrows)
with some undercondensed chromatin (short arrows). Images in g and h were recorded by a charge-coupled device camera, pseudocolored and
merged as described in Materials and Methods. (Red, chromatin; yellow, crystals; green, tubulin.). (X350.)
small spots within very young spermatocyte nuclei, whereas
cytoplasmic crystals, which appear star-shaped from the very
beginning of their growth, occupy variable positions among the
nuclei and noticeably increase in size in mature spermatocytes.
In the final stages of spermatogenesis, sperm bundles full of
crystals and containing various amounts of uncondensed chro-
matin (Fig. 2 g and h) are observed in cry- males. The
frequency of this type of abnormal sperm bundles correlates
with the number of Ste copies in the two genotypes examined.
These results indicate that the Ste protein constitutes a
major component of the crystalline aggregates.
Functional Homology Between the Ste Protein and the CK2
13 Subunit. The nondisjunction and chromosome condensation
defects observed in cry- males might be the consequence of a
mechanical disruption of meiosis and cell division caused by
the nuclear and cytoplasmic crystals. In this case, the Ste
protein might exert its effect simply by being expressed abun-
dantly enough to form crystalline aggregates. An alternative
possibility, based on the Ste homology to the CK2 ,B subunit (4,11, 12), is that Ste encodes an active component or interrupts
the function of CK2. To test this possibility, we assayed the
functional homology between the Ste protein and the f3 subunit
of CK2 by using an in vitro assay.
Previous studies have shown that the mammalian a subunit,
which is the catalytic subunit of CK2, assembles with the f
subunit in vitro to form a212 heterotetramers (23, 27-30).
When added in equimolar amounts, the Ste fusion protein fails
to interact with the CK2 a subunit (Fig. 3b). However, if the
concentration of the Ste fusion protein is increased up to a
molar excess of at least 10-fold over the a subunit, an increase
of basal catalytic activity is observed of the same order of that
induced by the 13 subunit (Fig. 3b). No stimulation of CK2
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FIG. 3. Biochemical characterization of the Stellate fusion protein in comparison human CK2 13 subunit. (a) Homology between the human
CK2 3 subunit and the Ste protein. The acidic domain (residues 55-70) responsible for down-regulation is boxed. (b) Stimulation of the catalytic
activity of the human CK2 a subunit by the ,B subunit and the Ste protein. Activity was monitored with the peptide substrate RRRAADSDDDDD
(1 mM) in the presence of 0.2 M urea. Numbers above the bars denote the molar ratio relative to the a subunit. (c) Thermal inactivation of the
human CK2 a subunit: protective effect of the ,B subunit (equimolar concentration) and the Ste protein (17-fold molar excess). Experimental
conditions are detailed under Materials and Methods. BSA, bovine serum albumin. (d) Sucrose density gradient ultracentrifugation of the Ste fusion
protein either alone (Upper) or added in a 17-fold molar excess to the human a subunit (Lower). Individual fractions were subjected to SDS/15%
PAGE analysis as described in Materials and Methods. The immunodetection of the Ste protein with specific Ste antibody on the blotted gels is
shown. The arrow denotes the position of CK2 activity peak along the gradient.
a-subunit activity is observed by replacing the Ste fusion
protein with equivalent concentration of bovine serum albu-
min (data not shown). Stimulation of catalytic activity is
evident only if Ste fusion protein is added to the catalytic a
subunit. On the contrary, the Ste fusion protein has no
stimulatory but rather a slightly inhibitory effect when it is
added to either rat liver CK2 or to reconstituted human CK2
holoenzyme, both exhibiting the heterotetrameric a2132 struc-
ture (data not shown). The lower affinity of the Ste fusion
protein for the CK2 a subunit as compared to the ( subunit,
even ifwe cannot exclude some effect due to the use of a fusion
protein, is probably due to their differences in the C-terminal
domain (residues 171-181 of the (3subunit) (see Fig. 3a), which
is known to be important for the interaction with the a subunit
(25).
A 17-fold molar excess of Ste fusion protein also prevents
thermal inactivation of the a subunit, thus mimicking the effect
of equimolar concentrations of the (3 subunit (Fig. 3c).
To gain more direct evidence about the interactions between
Ste protein and the CK2 a subunit, sucrose gradient ultracen-
trifugation experiments were performed. To overcome the
insolubility of the Ste fusion protein, ultracentrifugation was
performed in the presence of 0.2 M urea, which is compatible
with CK2 activity (30). These conditions, however, seem to
weaken the interactions between the Ste fusion protein and the
CK2 a subunit, thus hindering the clear-cut detection of
oligomeric complexes, which were monitored only in two
experiments out of three. However, also in the third experi-
ment, a positive interaction of the Ste fusion protein with the
CK2 a subunit was revealed by its immunodetection along the
gradient. As shown in Fig. 3d, the addition of the CK2 a
subunit results in significant amounts of the Ste fusion protein
displaying a decreased sedimentation coefficient, either comi-
grating with the CK2 a subunit (fraction 4) or smeared in
several fractions in the middle of the gradient (Lower). As
shown in Table 1, phosphorylation of calmodulin by the recon-
stituted a2132 holoenzyme is stimulated 15.8-fold by polylysine.
However, almost no effect of polylysine is observed when the
a subunit is in the presence of a 17-fold molar excess of Ste
fusion protein. As highlighted elsewhere (26), an acidic region
of the 3subunit, residues 55-64, is responsible for responsive-
ness to polylysine stimulation, which is especially evident with
calmodulin as a substrate. This region is not conserved in the
putative Ste product (see Fig. 3a).
Conclusions. Our data lead us to propose the following
model to explain the action of the Ste protein in spermatocytes
of cry- males. The functional homology of the Ste protein with
the (3 subunit of CK2 suggests that the Ste protein may
compete with the normal (3 subunit by binding to the a
catalytic subunit. This could give rise to oligomers with altered
activity and/or regulatory properties, as indicated by the lack
of stimulation by polylysine when the 3 subunit is replaced by
Ste fusion protein (see Table 1). Pertinent to this is the
observation that a number of CK2 targets are fully dependent
on these polybasic effectors (including several histones; ref. 26)
for their phosphorylation (e.g., calmodulin, ornithine decar-
boxylase, clathrin (3 light chain, and elongation factor 1). It
could be hypothesized therefore that in the presence of high
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Table 1. Failure of the Stellate protein to mediate polylysine
stimulation of calmodulin phosphorylation by human CK2
a subunit
Calmodulin
phosphorylation, cpm
+ polylysine Fold
Enzyme Control (84 nM) stimulation
a + ( (1:1) 507 8054 15.8
a + Ste (1:17) 856 1374 1.6
a and 3 refer to the a and , subunits of CK2.
Ste protein concentration, the activity of CK2 toward these
targets would be selectively decreased. This mode of regulation
could be especially effective in nuclei due to the nuclear
localization of histones, some of which have been shown to
surrogate for polylysine as activators of CK2 holoenzyme (26).
Topoisomerase II, together with DNA ligase I, is among the
nuclear CK2 targets whose activity is triggered by phosphor-
ylation (for review, see ref. 31). Consequently, a decreased
activity of topoisomerase II could be a major factor in causing
the spectrum ofchromosome alterations observed in cry- male
germ cells, although involvement of other meiotic proteins
regulated by CK2 cannot be excluded.
TIwo important points remain, however, to be clarified. One
is the mechanism by which crystal represses the Stellate
sequences. The second question is how the Ste loci maintain
their coding capacity despite the fact that they are normally
inactive and thus probably dispensable. The adventitious na-
ture of these sequences is indicated by the finding that, with the
exception of a single copy located in the Y chromosome of
Drosophila simulans, such sequences are not present in any
other member of the melanogaster group ofDrosophila (3). The
present data, showing the absence of Ste protein in normal
males, further support the suggestion that the Ste-cry system is
dispensable and, under this hypothesis, identify an evolution-
ary strategy evolved by a parasitic genetic system to actively
maintain itself. It consists in being nested into a meiotic
physiological process so intimately that it mimics essential
functions. Thus, any perturbation of cry-Ste system results in a
perturbation of the entire meiotic process, with a negative
impact on fitness.
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